Posts Tagged ‘genética’

Sunday July 05th, 2009

The GenoMEL Project Identifies a New Region of the Genome Associated With the Risk of Melanoma

The GenoMEL Project Identifies a New Region of the Genome Associated With the Risk of Melanoma

The genetic study includes 1650 patients and 4336 control subjects from Europe and Australia. Of the three regions of the genome with small variations identified as risk factors for melanoma, one is new and two are associated with pigmentation. These risk factors are shared despite genetic variability and differences in exposure to sunlight in the countries represented in the study.  IDIBAPS – Hospital Clínic is the only Spanish center in this project, which is led by Leeds University.

Read the rest of this entry »

Comments Closed
Wednesday May 06th, 2009

The Functions of Spermatozoa go Beyond Transmission of the Paternal Genome

D'esq. a dta.: el Dr. Rafael Oliva i la Dra. Sara Mateo, del grup d’Investigación en Genètica Humana del IDIBAPS-Hospital Clínic, i el Dr. Josep Maria Estanyol, de la Unitat de Proteòmica de la Facultad de Medicina de la Universitat de Barcelona.

According to an article published in the journal Proteomics (9(4):1004-17), certain human spermatozoon nuclear proteins associated with chromatin have epigenetic potential. This means that it may play a key role in the activation of some genes during initial embryonic development. The study was carried out by Dr. Rafael Oliva and Dr. Sara Mateo of the IDIBAPS-Hospital Clínic Human Genetics Research group, and Dr. Josep María Estanyol of the proteomics unit of the faculty of medicine at the University of Barcelona.

Read the rest of this entry »

Comments Closed
Tuesday February 24th, 2009

A New Technology Identifies Genes Implicated in the Development of Liver Cancer.

Dr. Augusto Villanueva i Dr. Josep Mª Llovet

This study, published in the journal Nature Biotechnology and led by Dr. Josep Maria Llovet of Hospital Clínic de  Barcelona – IDIBAPS together with researchers from the University of Minnesota (USA), describes for the first time a new technology for genetic manipulation in experimental animals for identifying therapeutic targets that facilitate the development of drugs that improve patient outcome.

Read the rest of this entry »

Comments Closed